Actively Recruiting
Understanding and Managing Pain in Inflammatory Joint Diseases Focusing on Biological and Targeted Synthetic DMARD Treatments
Led by Diakonhjemmet Hospital · Updated on 2026-04-13
350
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are exploring the causes and effects of chronic pain in patients with inflammatory joint diseases, focusing especially on central sensitization and cognitive function as key aspects of chronic pain. The study aims to identify different patient profiles and understand how risk factors affect pain, disease activity, and treatment outcomes over time in this group of patients. All participants will begin or switch to biological or targeted synthetic DMARD treatments, which are medications used to manage inflammatory joint diseases. The study is observational and tracks patients who receive these drug treatments as part of their care, without assigning or comparing different treatments within the trial. Participants will undergo various assessments including questionnaires about pain, anxiety, memory, and treatment expectations, as well as physical measurements like joint ultrasounds and MRI scans at the start and after three months. The main outcome measured is pain interference using the PROMIS Pain Interference Short Form. The study will monitor these factors longitudinally to learn more about pain mechanisms and treatment effects in inflammatory arthritis. The study is expected to continue until November 2027.
CONDITIONS
Brief Title
Pain in Inflammatory Joint Diseases
Research Team
I
Ida K Haugen, MD PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here